In this study, we sought to explore how the genetic deletion of glypican 1 altered the chemical composition of the glycocalyx and whether such changes could affect the lung endothelial barrier and overall pulmonary function to validate the use of global glypican 1 knockout mice to the study of pulmonary diseases and acute lung injury. The gene discussed is GPC1; the disease is injury.